Compound information
- Natural Products
- ZC2607606
- Molecular Formula
- C21H23ClN4O3
- Molecular Weight
- 414.145868276 g/mol
- Structure
-
- IUPAC Name
- (3-chloro-4-methyl-phenyl)-[4-[3-(cyclopropylamino)-4-nitro-phenyl]piperazin-1-yl]methanone
- InChI
- InChI=1S/C21H23ClN4O3/c1-14-2-3-15(12-18(14)22)21(27)25-10-8-24(9-11-25)17-6-7-20(26(28)29)19(13-17)23-16-4-5-16/h2-3,6-7,12-13,16,23H,4-5,8-11H2,1H3
- InChI Key
- NBMZQHCERBTIMT-UHFFFAOYSA-N
- SMILES
- Cc1ccc(C(=O)N2CCN(c3ccc([N+](=O)[O-])c(NC4CC4)c3)CC2)cc1Cl
- Source
- ZINC000004740990
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 29 | Ring Count | 4 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 78.72 Å2 | LogP | 4.377 |
LogS | -5.525 | LogD | 3.659 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.969 | Pgp substrate | 0.97 |
HIA | 0.963 | F20 % | 0.99 |
F30 % | 0.976 | Caco-2 | -4.848 |
MDCK | -5.125 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.006 | PPB | 96.99 |
VD | 1.798 | Fu | 1.504 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.013 | CYP1A2 substrate | 0.731 |
CYP2A6 substrate | 0.544 | CYP2B6 substrate | 0.682 |
CYP2C19 inhibitor | 0.85 | CYP2C19 substrate | 0.843 |
CYP2C8 substrate | 0.786 | CYP2C9 inhibitor | 0.912 |
CYP2C9 substrate | 0.499 | CYP2D6 inhibitor | 0.225 |
CYP2D6 substrate | 0.953 | CYP2E1 substrate | 0.303 |
CYP3A4 inhibitor | 0.869 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.199 | CL | 1.764 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.198 | Hepatotoxicity | 0.993 |
Mutagenicity | 0.976 | Rat Oral Acute Toxicity | 0.638 |
FDAMDD | 0.587 | Skin Sensitization | 0.989 |
Carcinogenicity | 0.392 | Eye Corrosion | 0.002 |
Eye Irritation | 0.087 | Respiratory Toxicity | 0.648 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.663 | IGC50 | 4.057 |
LC50FM | -8.927 | LC50DM | -1.454 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.823 | NR-AR-LBD | 0.464 |
NR-AhR | 0.795 | NR-Aromatase | 0.165 |
NR-ER | 0.666 | NR-ER-LBD | 0.68 |
NR-PPAR-gamma | 0.345 | SR-ARE | 0.86 |
SR-ATAD5 | 0.802 | SR-HSE | 0.812 |
SR-MMP | 0.67 | SR-p53 | 0.774 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.